Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04105387 · ClinicalTrials.gov registry record · NA

Tracheostomy Change

A NA study of Tracheostomy, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04105387: Completed NA study of Tracheostomy, sponsored by Children's Hospital of Philadelphia.

NCT04105387 is a NA study of Tracheostomy that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 16 participants, below the 41-participant average among 3 other Tracheostomy trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04105387, a NA study of Tracheostomy, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare outcomes of first tracheostomy change on postoperative day 4 to our current standard of care of first tracheostomy change on postoperative day 7.

Primary Outcome

This will be evaluated by analyzing a difference in proportions between the "day 4" group and "day 7" group for tracheostomy changes. This will be analyzed during the study participation, regardless of which group the subjects belong to. The analysis will be conducted using two-samples tests for difference in proportions between two study groups, using a two-sided chi-square test at significance level of 0.05.

Conditions Studied

Interventions

  • PROCEDURE Early Tracheostomy Change

Study Locations (1)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2017-08-14
Est. Completion 2021-02-19
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT04105387 record still lists

NCT04105387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 41-participant average among 3 other Tracheostomy trials with a reported enrollment target (61% lower).

The record links to 1 condition, with Tracheostomy appearing as the primary indexed condition, and to 1 intervention - of which Early Tracheostomy Change is the first listed.

NCT04105387 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04105387 about?

NCT04105387 is a clinical study titled "Tracheostomy Change". The purpose of this study is to compare outcomes of first tracheostomy change on postoperative day 4 to our current standard of care of first tracheostomy change on postoperative day 7.

What is the current status of trial NCT04105387?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-08-14. Estimated completion is 2021-02-19.

What conditions does trial NCT04105387 study?

This clinical trial studies the following conditions: Tracheostomy.

What interventions are being tested in trial NCT04105387?

The interventions under investigation include: Early Tracheostomy Change (PROCEDURE).

Who is sponsoring clinical trial NCT04105387?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04105387 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tracheostomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04105387, the US trial registry maintained by the National Library of Medicine. NCT04105387 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.